CourierPR

New York Cancer & Blood Specialists Welcomes Experienced Hematologist- Oncologist Dr. Jacob Levenson

New York Cancer & Blood Specialists2 min read1h ago

On August 31, 2026, New York Cancer & Blood Specialists (NYCBS), a leading oncology practice, welcomed Dr. Jacob Levenson, a hematologist-oncologist, to its team. This addition strengthens the clinical capabilities of NYCBS, which operates across Long Island, New York City, and the Hudson Valley.

Dr. Levenson will be based at the NYCBS office located at 2330 Eastchester Road in the Bronx. He brings extensive experience in managing complex solid tumors and hematologic malignancies, along with on-site oversight for chemotherapy and immunotherapy infusions. His expertise will be valuable in recognizing and managing infusion reactions and urgent oncologic complications, ensuring comprehensive care for patients.

Dr. Jeff Vacirca, CEO of NYCBS, expressed enthusiasm about the new addition. “We are pleased to welcome Dr. Levenson to our practice,” he stated. “His clinical experience, strong research background, and focus on advancing precision therapies in oncology make him a valuable asset to our team. We look forward to the expertise he will bring to our patients and our continued efforts to advance high-quality cancer care.”

Dr. Levenson’s clinical experience spans both inpatient and outpatient oncology settings. He earned his Doctor of Medicine from the University of Central Florida College of Medicine after completing a Bachelor of Science in Biology with a minor in Economics at Brandeis University. His medical training continued with an Internal Medicine Residency at the Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, and Long Island Jewish Medical Center, where he completed his Hematology Oncology Fellowship.

Dr. Levenson’s research focuses on liver-directed and precision therapies in gastrointestinal malignancies. His work includes research on hepatic artery infusion pump therapy for unresectable colorectal liver metastases, circulating tumor DNA during total neoadjuvant therapy for rectal cancer, and data analytics in pancreatic cancer. He is a co-first author of an American Society of Clinical Oncology Education Book chapter on liver-directed therapies in colorectal cancer and is a member of the American Society of Hematology and the American Society of Clinical Oncology.

“I am excited to join New York Cancer & Blood Specialists and contribute to a practice committed to advancing cancer care,” Dr. Levenson shared. “I look forward to applying my clinical and research experience to help improve treatment strategies and outcomes for patients while continuing to explore advances in precision oncology.”

For patients seeking appointments with Dr. Levenson, the number to call is (718) 732-4000. More information can be found on the NYCBS website at nycancer.com.

NYCBS is dedicated to providing world-class, patient-centered, and affordable care to individuals with cancer and blood disorders throughout New York State. With a mission to bring world-class cancer care close to home, the practice aims to support patients with the care and community they need during their treatment journey.